Most of the MM cases (85.71%) were positive for both conventional- and conventional-adapted pan-melanoma cocktail (triple positivity for HMB-45, tyrosinase, and SOX10) with a significantly higher rate compared with naevi (p < 0.0001). The gene discussed is PMEL; the disease is melanoma.